Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(67 sites)
United States
Research Site, Duarte, California Research Site, Irvine, California Research Site, Santa Monica, California Research Site, Santa Rosa, California Research Site, Shreveport, Louisiana